Giuseppe Marotta Selected Research

N- (adamantan- 1- yl)- 4- oxo- 1- pentyl- 6- phenyl- 1,4- dihydroquinoline- 3- carboxamide

1/2019

A Novel Highly Selective Cannabinoid CB2 Agonist Reduces in vitro Growth and TGF-beta Release of Human Glial Cell Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giuseppe Marotta Research Topics

Disease

3	Neoplasms (Cancer) 01/2022 - 01/2019
2	Hypoxia (Hypoxemia) 01/2022 - 01/2020
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 08/2006 - 01/2004
1	Primary Myelofibrosis (Myelosclerosis) 01/2021
1	Thrombosis (Thrombus) 01/2021
1	COVID-19 01/2021
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020
1	Leukemia 01/2020
1	Astrocytoma (Pilocytic Astrocytoma) 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Glioma (Gliomas) 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Multiple Sclerosis 10/2018
1	Osteomyelitis 04/2018
1	Ulcer 04/2018
1	Diabetic Foot 04/2018
1	Infections 11/2015
1	Visceral myopathy familial external ophthalmoplegia 10/2015
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2015
1	Liver Diseases (Liver Disease) 10/2015
1	Keratoconus 01/2008
1	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2007
1	Multiple Myeloma 04/2007
1	Hairy Cell Leukemia 08/2006
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2005
1	Aspergillosis 10/2005
1	Trisomy (Trisomies) 10/2004
1	Myopia 09/2004
1	Cataract (Cataracts) 09/2004
1	Neutropenia 01/2004
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2002

Drug/Important Bio-Agent (IBA)

3	fludarabineIBA 01/2021 - 01/2004
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 01/2004
2	Busulfan (Busulfex)FDA Link 01/2021 - 11/2015
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2018
2	Pharmaceutical PreparationsIBA 01/2019 - 10/2018
1	Messenger RNA (mRNA)IBA 01/2022
1	SAR405IBA 01/2022
1	CytokinesIBA 01/2022
1	LigandsIBA 01/2022
1	silk elastin-like protein (SELP)IBA 01/2021
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2021
1	bafilomycin A1IBA 01/2020
1	Chloroquine (Aralen)FDA LinkGeneric 01/2020
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2019
1	CannabinoidsIBA 01/2019
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2019
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2019
1	N- (adamantan- 1- yl)- 4- oxo- 1- pentyl- 6- phenyl- 1,4- dihydroquinoline- 3- carboxamideIBA 01/2019
1	CB2 Cannabinoid ReceptorIBA 01/2019
1	Tight Junction ProteinsIBA 10/2018
1	Fingolimod Hydrochloride (FTY720)FDA Link 10/2018
1	FibrinIBA 04/2018
1	AntigensIBA 10/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2007
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 04/2007
1	Pentostatin (Nipent)FDA LinkGeneric 08/2006
1	Interferon-alpha (Interferon Alfa)IBA 08/2006
1	Monoclonal AntibodiesIBA 01/2002
1	Rituximab (Mabthera)FDA Link 01/2002

Therapy/Procedure

3	Cell Transplantation 01/2021 - 04/2007
3	Transplantation 01/2020 - 10/2005
2	Therapeutics 04/2018 - 10/2005
2	Photorefractive Keratectomy 01/2008 - 09/2004
1	Haploidentical Transplantation 01/2020
1	Stem Cell Transplantation 10/2015
1	Aftercare (After-Treatment) 01/2008
1	Hematopoietic Stem Cell Transplantation 10/2005
1	Drug Therapy (Chemotherapy) 10/2004
1	Intraocular Lenses (Intraocular Lens) 09/2004